FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
krill oil 333.3 mg capsule
krill oil 500 mg capsule
labetalol hydrochloride 100 mg tablet
labetalol hydrochloride 200 mg tablet
labetalol hydrochloride 50 mg/10 mL injection, ampoule
lacosamide 10 mg/mL oral liquid
lacosamide 100 mg tablet
lacosamide 15 mg/mL oral liquid
lacosamide 150 mg tablet
lacosamide 200 mg/20 mL injection, vial
lacosamide 200 mg tablet
lacosamide 50 mg tablet
salicylic acid 20% + lactic acid 13.75% + podophyllum resin 10% paint
salicylic acid 16.7% + lactic acid 15% solution
salicylic acid 16.7% + lactic acid 16.7% solution
salicylic acid 17% + lactic acid 17% solution
urea 10% + lactic acid 5% cream
lactulose 3.3 g/5 mL oral liquid
lactulose 3.34 g/5 mL oral liquid
lactulose 3.4 g/5 mL oral liquid
lactulose 667 mg/mL oral liquid
lamivudine 10 mg/mL oral liquid
lamivudine 100 mg tablet
lamivudine 150 mg + zidovudine 300 mg tablet
lamivudine 150 mg tablet
lamivudine 300 mg tablet
lamivudine 5 mg/mL oral liquid
lamotrigine 100 mg dispersible tablet
lamotrigine 100 mg tablet
lamotrigine 2 mg tablet
lamotrigine 200 mg dispersible tablet
lamotrigine 200 mg tablet
lamotrigine 25 mg dispersible tablet
lamotrigine 25 mg tablet
lamotrigine 5 mg tablet
lamotrigine 50 mg dispersible tablet
lamotrigine 50 mg tablet
lanadelumab 300 mg/2 mL injection, syringe
lanadelumab 300 mg/2 mL injection, vial
liquid paraffin 80.7% + lanolin oil 2.64% oil
liquid paraffin 15.2% + lanolin oil 0.56% lotion
lanreotide 120 mg/0.5 mL injection, syringe
lanreotide 30 mg modified release injection, vial
lanreotide 60 mg/0.5 mL injection, syringe
lanreotide 90 mg/0.5 mL injection, syringe
lansoprazole 15 mg enteric capsule
lansoprazole 15 mg orally disintegrating tablet
lansoprazole 30 mg enteric capsule
lansoprazole 30 mg enteric coated granules, sachet
lansoprazole 30 mg orally disintegrating tablet
lanthanum 1 g chewable tablet
lanthanum 500 mg chewable tablet
lanthanum 750 mg chewable tablet
lapatinib 250 mg tablet
laronidase 500 units/5 mL injection, vial
larotrectinib 100 mg capsule
larotrectinib 20 mg/mL oral liquid
larotrectinib 25 mg capsule
latanoprost 0.005% + timolol 0.5% eye drops
latanoprost 0.005% eye drops
lauromacrogol-400 0.5% (10 mg/2 mL) injection, ampoule
lauromacrogol-400 1% (20 mg/2 mL) injection, ampoule
lauromacrogol-400 2% (40 mg/2 mL) injection, ampoule
lauromacrogol-400 3% (60 mg/2 mL) injection, ampoule
sodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema
ledipasvir 90 mg + sofosbuvir 400 mg tablet
leflunomide 10 mg tablet
leflunomide 100 mg tablet
leflunomide 20 mg tablet
lemborexant 10 mg tablet
lemborexant 5 mg tablet
lenacapavir 300 mg tablet
lenacapavir 463.5 mg/1.5 mL injection, vial
lenalidomide 10 mg capsule
lenalidomide 15 mg capsule
lenalidomide 2.5 mg capsule
lenalidomide 20 mg capsule
lenalidomide 25 mg capsule
lenalidomide 5 mg capsule
lenalidomide 7.5 mg capsule
lenograstim 13.4 million units (105 microgram) injection, vial
lenograstim 263 microgram injection, 263 microgram vial (medicinal product unit of use)
lenvatinib 10 mg capsule
lenvatinib 4 mg capsule
lepirudin 50 mg injection, vial
lercanidipine hydrochloride 10 mg tablet
lercanidipine hydrochloride 20 mg tablet
lesinurad 200 mg tablet
letermovir 240 mg/12 mL injection, vial
letermovir 240 mg tablet
letermovir 480 mg/24 mL injection, vial
letermovir 480 mg tablet
letrozole 2.5 mg tablet
leuprorelin acetate 1 mg/0.2 mL injection, vial
leuprorelin acetate 22.5 mg modified release injection, chamber
leuprorelin acetate 22.5 mg modified release injection, syringe
leuprorelin acetate 3.75 mg modified release injection, vial
leuprorelin acetate 30 mg modified release injection, chamber
leuprorelin acetate 30 mg modified release injection, syringe
leuprorelin acetate 45 mg modified release injection, chamber
leuprorelin acetate 45 mg modified release injection, syringe

Start Previous Page 47 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start